OMRON Healthcare, a global leader in heart health innovation, announced the launch of its next-generation blood pressure monitors featuring Intellisense™ AFib, the world’s first AI-powered atrial fibrillation (AFib) detection technology integrated directly into a home-use medical device. This revolutionary enhancement allows users to automatically screen for AFib with every single blood pressure measurement, redefining preventive heart care for millions.

A published clinical study found that OMRON monitors with Intellisense™ AFib can detect AFib-specific disturbances with remarkable accuracy. Leveraging a proprietary machine learning algorithm and over 300 mathematical indices, the technology analyzes Pressure Pulse Waves during cuff inflation—identifying early indicators of AFib, a condition linked to increased risk of stroke, heart failure, and dementia.

“OMRON is evolving the home blood pressure monitoring experience by making AFib screening a routine part of every measurement,” said Alice Koehler, Managing Director, OMRON Healthcare U.S. “AFib is a serious, often undiagnosed condition. With Intellisense™ AFib, we aim to enable earlier detection and empower users to take action before serious complications arise.”

Powerful Devices with Proven Performance

The new monitors are clinically accurate, FDA-authorized via De Novo classification, and fully compatible with the OMRON Connect app, offering seamless health tracking via iOS® and Android®:

• OMRON Platinum BP5465: Dual-display with storage for 200 readings (100/user), ranked “Best Home BP Monitor” by The New York Times Wirecutter.

• OMRON 10 Series® BP7465: Large display, TruRead™ tech, and 200-reading memory, recommended by Consumer Reports.

• OMRON 7 Series® BP7360: Compact, easy-to-read, and stores 120 readings; rated a “Best of 2025” by Health & Living.

• OMRON Gold BP5360: Premium design with 160-reading capacity and praised by BPM Reviews for accuracy and ease of use.

Beyond Monitoring: Educating and Empowering Consumers

OMRON is also launching an AFib Education Hub, offering resources about the condition, its risk factors, and how Intellisense™ AFib works. The OMRON Connect app extends this education with personalized insights, trend tracking, and the ability to share reports with physicians.

AFib affects millions—often unknowingly—and accelerates in prevalence after age 40. Recent research from The Journal of the American College of Cardiology indicates AFib is three times more common than previously estimated. According to the American Stroke Association, many cases go undetected, even as risks escalate with conditions like high blood pressure, diabetes, and sleep apnea.

“Research shows that 90% of strokes and heart attacks are preventable,” added Koehler. “With Intellisense™ AFib, OMRON is giving consumers unmatched access to proactive, AI-powered heart health—right from their homes.”